Aperia A, Ibarra F, Svensson L B, Klee C, Greengard P
Department of Pediatrics, St. Göran's Children's Hospital, Karolinska Institutet, Stockholm, Sweden.
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7394-7. doi: 10.1073/pnas.89.16.7394.
The alpha-adrenergic agonist oxymetazoline increased Na+,K(+)-ATPase activity of single proximal convoluted tubules dissected from rat kidney. Activation of the enzyme by oxymetazoline was prevented by either the alpha 1-adrenergic antagonist prazosin or the alpha 2-adrenergic antagonist yohimbine and was mimicked by the calcium ionophore A23187. The effect of oxymetazoline on Na+,K(+)-ATPase activity was prevented by a specific peptide inhibitor of calcineurin, as well as by FK 506, an immunosuppressant agent known to inhibit calcineurin; these results indicate that the action of oxymetazoline is mediated via activation of calcineurin (a calcium/calmodulin-dependent protein phosphatase). Activation of the Na+,K(+)-ATPase by either oxymetazoline or A23187 was associated with a greater than 2-fold increase in its affinity for Na+. The results provide a biochemical mechanism by which norepinephrine, released from renal nerve terminals, stimulates Na+ retention.
α-肾上腺素能激动剂羟甲唑啉可增加从大鼠肾脏分离出的单个近端曲管的Na⁺,K⁺-ATP酶活性。α₁-肾上腺素能拮抗剂哌唑嗪或α₂-肾上腺素能拮抗剂育亨宾均可阻止羟甲唑啉对该酶的激活,而钙离子载体A23187可模拟其作用。钙调神经磷酸酶的特异性肽抑制剂以及已知可抑制钙调神经磷酸酶的免疫抑制剂FK506均可阻止羟甲唑啉对Na⁺,K⁺-ATP酶活性的影响;这些结果表明,羟甲唑啉的作用是通过激活钙调神经磷酸酶(一种钙/钙调蛋白依赖性蛋白磷酸酶)介导的。羟甲唑啉或A23187对Na⁺,K⁺-ATP酶的激活与该酶对Na⁺的亲和力增加2倍以上有关。这些结果提供了一种生化机制,通过该机制,从肾神经末梢释放的去甲肾上腺素可刺激Na⁺潴留。